Discussion about this post

User's avatar
Fred's avatar

I have to say i don't agree with that characterisation of MCK - their own mid term targets are for 6-8% operating profit growth. Is there any reason you think they will grow more like 3-5%?

Part of why i like it is that i think the business mix has shifted towards specialty which is a structurally higher growth category than generics which used to make up the bulk of operating profits. Of course they don't disclose this exactly ... why potentially creates the opportunity!

Expand full comment

No posts